213 related articles for article (PubMed ID: 17350137)
1. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.
Tsuchiya T; Akamine S; Muraoka M; Kamohara R; Tsuji K; Urabe S; Honda S; Yamasaki N
Lung Cancer; 2007 Jun; 56(3):341-8. PubMed ID: 17350137
[TBL] [Abstract][Full Text] [Related]
2. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.
Tsuchiya T; Kamohara R; Muraoka M; Nagayasu T; Saeki S; Takenoyama M; Suzuki M; Inada K; Tokunaga S; Hayashi T; Urabe S; Koga T; Akamine S; Sugio K
BMC Cancer; 2020 Dec; 20(1):1192. PubMed ID: 33276755
[TBL] [Abstract][Full Text] [Related]
3. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of pathologic stage IB non-small cell lung cancer.
Yano M; Sasaki H; Moriyama S; Kawano O; Hikosaka Y; Fujii Y
Ann Thorac Cardiovasc Surg; 2011; 17(1):58-62. PubMed ID: 21587131
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral gene expression of 5-fluorouracil pharmacokinetics-related enzymes in stage I and II non-small cell lung cancer patients treated with uracil-tegafur after surgery: a prospective multi-institutional study in Japan.
Eguchi K; Oyama T; Tajima A; Abiko T; Sawafuji M; Horio H; Hashizume T; Matsutani N; Kato R; Nakayama M; Kawamura M; Kobayashi K
Lung Cancer; 2015 Jan; 87(1):53-8. PubMed ID: 25468199
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
8. Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
Soh J; Toyooka S; Okumura N; Nakamura H; Nakata M; Yamashita M; Sakamoto J; Aoe M; Hotta K; Morita S; Date H
Int J Clin Oncol; 2019 Nov; 24(11):1367-1376. PubMed ID: 31312931
[TBL] [Abstract][Full Text] [Related]
9. Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials.
Hamada C; Tsuboi M; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
J Thorac Oncol; 2009 Dec; 4(12):1511-6. PubMed ID: 19875974
[TBL] [Abstract][Full Text] [Related]
10. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
[TBL] [Abstract][Full Text] [Related]
11. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
Wada H; Miyahara R; Tanaka F; Hitomi S
Eur J Cardiothorac Surg; 1999 Apr; 15(4):438-43. PubMed ID: 10371118
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
Wang S; Xu J; Wang R; Qian F; Yang W; Qiao R; Zhang B; Qian J; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Nov; 156(5):2006-2015.e2. PubMed ID: 30104070
[TBL] [Abstract][Full Text] [Related]
13. Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer.
Tsuchiya T; Hashizume S; Akamine S; Muraoka M; Honda S; Tsuji K; Urabe S; Hayashi T; Yamasaki N; Nagayasu T
Chest; 2007 Jul; 132(1):170-7. PubMed ID: 17505030
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer.
Tanaka F; Yanagihara K; Otake Y; Miyahara R; Wada H
Cancer Sci; 2004 Apr; 95(4):371-6. PubMed ID: 15072598
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Kato H; Ichinose Y; Ohta M; Hata E; Tsubota N; Tada H; Watanabe Y; Wada H; Tsuboi M; Hamajima N; Ohta M;
N Engl J Med; 2004 Apr; 350(17):1713-21. PubMed ID: 15102997
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for disease-free survival in pT2N0 non-small cell lung cancer.
Park I; Chung KY; Kim KD; Kim DJ
Asian Cardiovasc Thorac Ann; 2006 Apr; 14(2):139-44. PubMed ID: 16551822
[TBL] [Abstract][Full Text] [Related]
17. Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701.
Soh J; Okumura N; Nakata M; Nakamura H; Fukuda M; Kataoka M; Kajiwara S; Sano Y; Aoe M; Kataoka K; Hotta K; Matsuo K; Toyooka S; Date H
Jpn J Clin Oncol; 2016 Aug; 46(8):741-7. PubMed ID: 27207886
[TBL] [Abstract][Full Text] [Related]
18. Study of prognostic predictors for non-small cell lung cancer.
Fu XL; Zhu XZ; Shi DR; Xiu LZ; Wang LJ; Zhao S; Qian H; Lu HF; Xiang YB; Jiang GL
Lung Cancer; 1999 Feb; 23(2):143-52. PubMed ID: 10217618
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.
Shoji F; Haro A; Yoshida T; Ito K; Morodomi Y; Yano T; Maehara Y
Ann Thorac Surg; 2010 Mar; 89(3):864-9. PubMed ID: 20172144
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of uncertain parietal pleural invasion at adhesion sites in non-small cell lung cancer patients.
Mikubo M; Nakashima H; Naito M; Matsui Y; Shiomi K; Jiang SX; Satoh Y
Lung Cancer; 2017 Jun; 108():103-108. PubMed ID: 28625620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]